Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MadeMed vs telos rx

By GLP-1 ScorecardUpdated

MadeMed
Site position #35

Lower score

telos rxFactor scores not reassessed.
Site position #13

Higher score

Score comparison

telos rx has the higher recorded score — 85.4/100 to 80.4/100.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers compounded oral and injectable formats; discounted plans can carry early-exit adjustments.

Before you choose

Before comparing the headline prices, the MadeMed review and the telos rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, MadeMed vs Tru2u and MyDrHank vs telos rx compare each of them with another graded program, and the list of alternatives to MadeMed ranks the programs closest to MadeMed on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Found review covers one graded close to these two, at 83.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuetelos rx +13
74
87
Dose & formulationEven
90
90
Clinical oversightEven
84
84
Labs & monitoringtelos rx +18
62
80
FulfillmentMadeMed +3
90
87
Contract termsMadeMed +8
88
80
MadeMed · top bartelos rx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMadeMedtelos rx
WeighScore80.4/10085.4/100
GradeB−B
Site position#35#13
Semaglutide$179 every 30 days; $483/90 days or $1,718/360 days ($143.17 equivalent per 30 days); consultation fees and usable supply require confirmationAdvertised from $99/month injectable; plan-dependent; selected bill unverified.
TirzepatideInjection or sublingual: $249 every 30 days; $672/90 days or $2,390/360 days ($199.17 equivalent per 30 days); final fees and supply unverifiedAdvertised from $139/month injectable; from $116/month microdosed injection; selected bills unverified.
CoverageConfirm selected treatment/state: sublingual tirzepatide FAQ lists 40 states; current injection-state map unverifiedAdvertises all 50 states; pharmacy and formulation availability varies.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
MadeMed

Site position #35 · B−

Strengths

  • Public selectors show full charges for 30-, 90- and 360-day plans across the listed GLP-1 products
  • Advertises the same pricing across doses, ongoing clinical messaging and included injection supplies
  • Current terms name MDI Medical Group PC and four partner pharmacy brands
  • A 30-day purchase is advertised alongside the larger prepaid options

What to consider

  • Lowest advertised equivalents require $1,718/$2,390 360-day billing plans; terms reject prorated refunds
  • Product pages list $20/$30 consultation fees while How It Works says consultation is included and ineligible payments are refunded in full
  • The forty-state claim is specific to sublingual tirzepatide; an injection-state map was not established
  • Assigned clinician/pharmacy branch, patient lab costs, final first debit and usable prescription supply remain unresolved
telos rx

Site position #13 · B

Factor scores not reassessed.

Strengths

  • Names its care organization and pharmacy partners
  • Oral and injectable compounded options

What to consider

  • Early cancellation can reprice supplied months
  • Entity, denial-refund and lab terms conflict
  • Current oral invoice and renewal price unverified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard